Friday, December 15, 2017
 
 
Company News: Page (1) of 1 - 10/20/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
US Rheumatologists Teed Up for Rapid Adoption of BMS' Orencia in Psoriatic Arthritis, Though the Real Game Changer Could Come with the Approval of Pfizer's Xeljanz
Half of all surveyed rheumatologists agree a new oral small molecule would be of greater use in psoriatic arthritis than any additional alternative mechanism of action biologic, according to recent fi...
(October 20, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Medicine,Disease,Surgery,Physician,Science,Medical,Biology,Business,Medical Professionals,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines